The role of Piccolo in cancer treatment: relationship with EGFR and related therapies, and a marker for new targeted therapies

Affiliations

Editorial

Milo Frattini et al. J Thorac Dis. 2017 Nov.

. 2017 Nov;9(11):4240-4243.

doi: 10.21037/jtd.2017.10.38.

¹ Laboratory of Molecular Pathology, Institute of Pathology, Locarno, Switzerland.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Piccolo mediates EGFR signaling and acts as a prognostic biomarker in esophageal squamous cell carcinoma.
Zhang W, Hong R, Xue L, Ou Y, Liu X, Zhao Z, Xiao W, Dong D, Dong L, Fu M, Ma L, Lu N, Chen H, Song Y, Zhan Q. Zhang W, et al. Oncogene. 2017 Jul 6;36(27):3890-3902. doi: 10.1038/onc.2017.15. Epub 2017 Mar 6. Oncogene. 2017. PMID: 28263981

1. Song Y, Li L, Ou Y, et al. Identification of genomic alterations in oesophageal squamous cell cancer. Nature 2014;509:91-5. 10.1038/nature13176 - DOI - PubMed
1. Higuchi K, Koizumi W, Tanabe S, et al. Current management of esophageal squamous-cell carcinoma in Japan and other countries. Gastrointest Cancer Res 2009;3:153-61. - PMC - PubMed
1. Zhang W, Hong R, Xue L, et al. Piccolo mediates EGFR signaling and acts as a prognostic biomarker in esophageal squamous cell carcinoma. Oncogene 2017;36:3890-902. 10.1038/onc.2017.15 - DOI - PubMed
1. Zhai RG, Vardinon-Friedman H, Cases-Langhoff C, et al. Assembling the presynaptic active zone: a characterization of an active one precursor vesicle. Neuron 2001;29:131-43. 10.1016/S0896-6273(01)00185-4 - DOI - PubMed
1. Fenster SD, Kessels MM, Qualmann B, et al. Interactions between piccolo and the actin/dynamin-binding protein Abp1 link vesicles endocytosis to presynaptic active zones. J Biol Chem 2003;278:20268-77. 10.1074/jbc.M210792200 - DOI - PubMed